-
The ED at Gifford Medical Center in Randolph, VT, was crowded when a patient presented with acute anaphylaxis. The patient was treated immediately, and no errors occurred.
-
Have you inserted arterial or central lines, performed invasive pressure monitoring, or managed a mechanically ventilated patient in your ED recently?
-
On Oct. 18, 2010, the FDA granted tentative approval to fixed-dose combination lamivudine/zidovudine tablets, 150 mg/300 mg, indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults.
-
Post-marketing surveillance outside the United States of the two FDA-licensed rotavirus vaccines, RotaTeq (Merck, licensed in 2006) and Rotarix (GSK Biologicals, licensed in 2008), have identified a very low but increased risk (1 case/100,000 vaccinated infants) of intussusception following Rotarix vaccination.
-
Get ready to recommend flu vaccine to your pregnant and postpartum patients. According to the Centers for Disease Control and Prevention (CDC), less than one-fourth of pregnant women in the United States were vaccinated against seasonal influenza during the 2007-08 flu season.
-
-
In this issue: Rivaroxaban may be dabigatran's first competitor; a new way to measure non-adherence to medication therapy; FDA Actions.
-
-
-
Protocol review consistency is a hot topic as IRBs, research organizations, and investigators struggle with balancing quality and efficiency in the review process.